{"id":"https://openalex.org/W4366523830","doi":"https://doi.org/10.1158/1078-0432.c.6608869","title":"Data from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis","display_name":"Data from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis","publication_year":2023,"publication_date":"2023-04-20","ids":{"openalex":"https://openalex.org/W4366523830","doi":"https://doi.org/10.1158/1078-0432.c.6608869"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6608869","doi":"https://doi.org/10.1158/1078-0432.c.6608869","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6608869","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6608869","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055282224","display_name":"Chong Kin Liam","orcid":"https://orcid.org/0000-0002-3639-9231","observed_orcids":["https://orcid.org/0000-0002-3639-9231"]},"institutions":[{"id":"https://openalex.org/I33849332","display_name":"University of Malaya","ror":"https://ror.org/00rzspn62","country_code":"MY","type":"education","lineage":["https://openalex.org/I33849332"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Chong Kin Liam","raw_affiliation_strings":["Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia"],"raw_orcid":"https://orcid.org/0000-0002-3639-9231","affiliations":[{"raw_affiliation_string":"Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia","institution_ids":["https://openalex.org/I33849332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030416477","display_name":"Azura Rozila Ahmad","orcid":"https://orcid.org/0000-0003-3301-8656","observed_orcids":["https://orcid.org/0000-0003-3301-8656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Azura Rozila Ahmad","raw_affiliation_strings":["Beacon International Specialist Centre Sdn Bhd, Selangor, Malaysia"],"raw_orcid":"https://orcid.org/0000-0003-3301-8656","affiliations":[{"raw_affiliation_string":"Beacon International Specialist Centre Sdn Bhd, Selangor, Malaysia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074784103","display_name":"Te\u2010Chun Hsia","orcid":"https://orcid.org/0000-0003-4297-9918","observed_orcids":["https://orcid.org/0000-0003-4297-9918","https://orcid.org/0000-0002-7294-7055"]},"institutions":[{"id":"https://openalex.org/I4210126829","display_name":"China Medical University Hospital","ror":"https://ror.org/0368s4g32","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210126829"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Te-Chun Hsia","raw_affiliation_strings":["China Medical University Hospital, Taichung City, Taiwan"],"raw_orcid":"https://orcid.org/0000-0003-4297-9918","affiliations":[{"raw_affiliation_string":"China Medical University Hospital, Taichung City, Taiwan","institution_ids":["https://openalex.org/I4210126829"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052132950","display_name":"Jianying Zhou","orcid":"https://orcid.org/0000-0002-8924-935X","observed_orcids":["https://orcid.org/0000-0002-8924-935X","https://orcid.org/0009-0003-7889-3451"]},"institutions":[{"id":"https://openalex.org/I4210166576","display_name":"First Affiliated Hospital Zhejiang University","ror":"https://ror.org/05m1p5x56","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166576"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianying Zhou","raw_affiliation_strings":["The First Affiliated Hospital, Zhejiang University, Hangzhou, China"],"raw_orcid":"https://orcid.org/0000-0002-8924-935X","affiliations":[{"raw_affiliation_string":"The First Affiliated Hospital, Zhejiang University, Hangzhou, China","institution_ids":["https://openalex.org/I4210166576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100638261","display_name":"Dong\u2010Wan Kim","orcid":"https://orcid.org/0000-0001-5124-7132","observed_orcids":["https://orcid.org/0000-0001-5124-7132"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Dong-Wan Kim","raw_affiliation_strings":["Seoul National University Hospital, Seoul, South Korea"],"raw_orcid":"https://orcid.org/0000-0001-5124-7132","affiliations":[{"raw_affiliation_string":"Seoul National University Hospital, Seoul, South Korea","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032293215","display_name":"Ross Andrew Soo","orcid":"https://orcid.org/0000-0002-3053-3997","observed_orcids":["https://orcid.org/0000-0002-3053-3997"]},"institutions":[{"id":"https://openalex.org/I4210103786","display_name":"National University Cancer Institute, Singapore","ror":"https://ror.org/025yypj46","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I4210103786","https://openalex.org/I4210150261"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Ross Andrew Soo","raw_affiliation_strings":["National University Cancer Institute, Singapore"],"raw_orcid":"https://orcid.org/0000-0002-3053-3997","affiliations":[{"raw_affiliation_string":"National University Cancer Institute, Singapore","institution_ids":["https://openalex.org/I4210103786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057704753","display_name":"Ying Cheng","orcid":"https://orcid.org/0000-0001-9908-597X","observed_orcids":["https://orcid.org/0000-0001-9908-597X","https://orcid.org/0009-0006-2718-2969"]},"institutions":[{"id":"https://openalex.org/I4210098607","display_name":"Jilin Province Tumor Hospital","ror":"https://ror.org/00vgek070","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098607"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ying Cheng","raw_affiliation_strings":["Jilin Province Cancer Hospital, Changchun, China"],"raw_orcid":"https://orcid.org/0000-0001-9908-597X","affiliations":[{"raw_affiliation_string":"Jilin Province Cancer Hospital, Changchun, China","institution_ids":["https://openalex.org/I4210098607"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004928583","display_name":"Shun L\u00fc","orcid":"https://orcid.org/0000-0001-8833-7262","observed_orcids":["https://orcid.org/0000-0001-8833-7262"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2802608112","display_name":"Shanghai Chest Hospital","ror":"https://ror.org/03fjc3817","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802608112"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shun Lu","raw_affiliation_strings":["Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"],"raw_orcid":"https://orcid.org/0000-0001-8833-7262","affiliations":[{"raw_affiliation_string":"Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2802608112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057550966","display_name":"Sang Won Shin","orcid":"https://orcid.org/0000-0002-9182-1589","observed_orcids":["https://orcid.org/0000-0002-9182-1589"]},"institutions":[{"id":"https://openalex.org/I4405260934","display_name":"Korea University Anam Hospital","ror":"https://ror.org/04gjj3027","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I197347611","https://openalex.org/I2799980853","https://openalex.org/I4405260934"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sang Won Shin","raw_affiliation_strings":["Korea University Anam Hospital, Seoul, South Korea"],"raw_orcid":"https://orcid.org/0000-0002-9182-1589","affiliations":[{"raw_affiliation_string":"Korea University Anam Hospital, Seoul, South Korea","institution_ids":["https://openalex.org/I4405260934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"James Chih-Hsin Yang","raw_affiliation_strings":["National Taiwan University Hospital, Taipei, Taiwan"],"raw_orcid":"https://orcid.org/0000-0002-5586-5138","affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080162254","display_name":"Yiping Zhang","orcid":"https://orcid.org/0009-0000-2833-8626","observed_orcids":["https://orcid.org/0009-0000-2833-8626"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yiping Zhang","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":"https://orcid.org/0009-0000-2833-8626","affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100681890","display_name":"Jun Zhao","orcid":"https://orcid.org/0000-0003-1464-7158","observed_orcids":["https://orcid.org/0000-0003-1464-7158"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jun Zhao","raw_affiliation_strings":["Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":"https://orcid.org/0000-0003-1464-7158","affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030186225","display_name":"Karin Berghoff","orcid":"https://orcid.org/0000-0002-6310-3379","observed_orcids":["https://orcid.org/0000-0002-6310-3379"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]},{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Karin Berghoff","raw_affiliation_strings":["Global Patient Safety, the healthcare business of Merck KGaA, Darmstadt, Germany"],"raw_orcid":"https://orcid.org/0000-0002-6310-3379","affiliations":[{"raw_affiliation_string":"Global Patient Safety, the healthcare business of Merck KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055627152","display_name":"Rolf Bruns","orcid":"https://orcid.org/0000-0003-2305-3765","observed_orcids":["https://orcid.org/0000-0003-2305-3765"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]},{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rolf Bruns","raw_affiliation_strings":["Department of Biostatistics, the healthcare business of Merck KGaA, Darmstadt, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2305-3765","affiliations":[{"raw_affiliation_string":"Department of Biostatistics, the healthcare business of Merck KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005665121","display_name":"Andreas Johne","orcid":"https://orcid.org/0000-0003-2690-2857","observed_orcids":["https://orcid.org/0000-0003-2690-2857"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]},{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Johne","raw_affiliation_strings":["Global Clinical Development, the healthcare business of Merck KGaA, Darmstadt, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2690-2857","affiliations":[{"raw_affiliation_string":"Global Clinical Development, the healthcare business of Merck KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100632072","display_name":"Yi-Long Lung Cancer Wu","orcid":"https://orcid.org/0000-0002-3611-0258","observed_orcids":["https://orcid.org/0000-0002-3611-0258"]},"institutions":[{"id":"https://openalex.org/I4210145693","display_name":"Guangdong Academy of Medical Sciences","ror":"https://ror.org/0432p8t34","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210145693"]},{"id":"https://openalex.org/I4210153930","display_name":"Guangdong Provincial People's Hospital","ror":"https://ror.org/045kpgw45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi-Long Wu","raw_affiliation_strings":["Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China","Institute grants and personal fees: AstraZeneca, Roche, Boehringer Ingelheim"],"raw_orcid":"https://orcid.org/0000-0002-3611-0258","affiliations":[{"raw_affiliation_string":"Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China","institution_ids":["https://openalex.org/I4210145693","https://openalex.org/I4210153930"]},{"raw_affiliation_string":"Institute grants and personal fees: AstraZeneca, Roche, Boehringer Ingelheim","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tepotinib","display_name":"tepotinib","score":0.875},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.9909999966621399},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.8619999885559082},{"id":"https://openalex.org/keywords/met-inhibitors","display_name":"MET inhibitors","score":0.6359999775886536},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5950000286102295},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.871999979019165},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9570000171661377},{"id":"https://openalex.org/keywords/chemotherapy-comparison","display_name":"chemotherapy comparison","score":0.5400000214576721},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.5889999866485596},{"id":"https://openalex.org/keywords/insight-trial","display_name":"INSIGHT trial","score":0.7300000190734863},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5529999732971191},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.382999986410141},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.815132737159729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6760085821151733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.530584990978241},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.495157390832901},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4146696925163269},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3525356352329254},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3323521018028259},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26594078540802},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.23121103644371033}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6608869","doi":"https://doi.org/10.1158/1078-0432.c.6608869","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6608869","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6608869","doi":"https://doi.org/10.1158/1078-0432.c.6608869","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6608869","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1670422463","display_name":null,"funder_award_id":"10.13039/100009945","funder_id":"https://openalex.org/F4320311647","funder_display_name":"Merck KGaA"},{"id":"https://openalex.org/G490769284","display_name":null,"funder_award_id":"100009945","funder_id":"https://openalex.org/F4320311647","funder_display_name":"Merck KGaA"}],"funders":[{"id":"https://openalex.org/F4320311647","display_name":"Merck KGaA","ror":"https://ror.org/04b2dty93"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W2004202575","https://openalex.org/W2544185683","https://openalex.org/W2765258454","https://openalex.org/W2789842110","https://openalex.org/W2794026637","https://openalex.org/W2802552316","https://openalex.org/W2944586186","https://openalex.org/W2954565338","https://openalex.org/W2969837032","https://openalex.org/W2976334328","https://openalex.org/W2995360881","https://openalex.org/W3029971508","https://openalex.org/W3118874405","https://openalex.org/W3138307077","https://openalex.org/W3154466284","https://openalex.org/W3188690607","https://openalex.org/W3203640019","https://openalex.org/W3206982798","https://openalex.org/W3209324958","https://openalex.org/W3214844045","https://openalex.org/W4200417352","https://openalex.org/W4223415363","https://openalex.org/W4245648150","https://openalex.org/W4283731594","https://openalex.org/W4294935045","https://openalex.org/W4294939450","https://openalex.org/W4295819481","https://openalex.org/W4296767519","https://openalex.org/W4297982030"],"related_works":["https://openalex.org/W4361000448","https://openalex.org/W4282967501","https://openalex.org/W2990369889","https://openalex.org/W4318303054","https://openalex.org/W4310754862","https://openalex.org/W3029971508","https://openalex.org/W4294939450","https://openalex.org/W2991074819","https://openalex.org/W2955811607","https://openalex.org/W2981609990"],"abstract_inverted_index":{"AbstractPurpose:":[0],"The":[1],"final":[2],"analyses":[3],"of":[4,172,182,226,242],"the":[5],"INSIGHT":[6,227],"phase":[7],"II":[8],"study":[9],"evaluating":[10],"tepotinib":[11,61,108,136,163,183,215,234],"(a":[12],"selective":[13],"MET":[14,46,55,117,133],"inhibitor)":[15],"plus":[16,68,109,137,164,184,216,235],"gefitinib":[17,69,110,138,165,185,217,236],"versus":[18,98,111,155,166,177,237],"chemotherapy":[19,238],"in":[20,195,201,239],"patients":[21,115,203,206,243],"with":[22,35,107,116,132,162,168,191,214,233,244],"MET-altered":[23],"EGFR-mutant":[24,37,246],"NSCLC":[25],"(data":[26],"cut-off:":[27],"September":[28],"3,":[29],"2021).":[30],"Patients":[31],"and":[32,45,146,198,218,231],"Methods:":[33],"Adults":[34],"advanced/metastatic":[36],"NSCLC,":[38,247],"acquired":[39],"resistance":[40],"to":[41,60],"first-/second-generation":[42],"EGFR":[43,251],"inhibitors,":[44],"gene":[47],"copy":[48],"number":[49],"(GCN)":[50],"\u22655,":[51],"MET:CEP7":[52],"\u22652,":[53],"or":[54,74],"IHC":[56,134],"2+/3+":[57],"were":[58],"randomized":[59],"500":[62],"mg":[63,65,71],"(450":[64],"active":[66],"moiety)":[67],"250":[70],"once":[72],"daily,":[73],"chemotherapy.":[75,112,156,222],"Primary":[76],"endpoint":[77],"was":[78,86,95,160,174,186],"investigator-assessed":[79],"progression-free":[80],"survival":[81,148],"(PFS).":[82],"MET-amplified":[83,245],"subgroup":[84,241],"analysis":[85,225],"preplanned.":[87],"Results:":[88],"Overall":[89],"(N":[90],"=":[91],"55),":[92],"median":[93,125,128,170],"PFS":[94,140,230],"4.9":[96],"months":[97,100,176,188],"4.4":[99],"[stratified":[101],"HR,":[102,150],"0.67;":[103],"90%":[104,143,152],"CI,":[105,144,153],"0.35\u20131.28]":[106],"In":[113],"19":[114],"amplification":[118],"(median":[119],"age":[120],"60.4":[121],"years;":[122],"68.4%":[123],"never-smokers;":[124],"GCN":[126],"8.8;":[127],"MET/CEP7":[129],"2.8;":[130],"89.5%":[131],"3+),":[135],"improved":[139,229],"(HR,":[141],"0.13;":[142],"0.04\u20130.43)":[145],"overall":[147],"(OS;":[149],"0.10;":[151],"0.02\u20130.36)":[154],"Objective":[157],"response":[158,173],"rate":[159],"66.7%":[161],"42.9%":[167],"chemotherapy;":[169],"duration":[171,181],"19.9":[175],"2.8":[178],"months.":[179],"Median":[180],"11.3":[187],"(range,":[189],"1.1\u201356.5),":[190],"treatment":[192],">1":[193],"year":[194],"six":[196],"(50.0%)":[197],">4":[199],"years":[200],"three":[202],"(25.0%).":[204],"Seven":[205],"(58.3%)":[207],"had":[208,221],"treatment-related":[209],"grade":[210],"\u22653":[211],"adverse":[212],"events":[213],"five":[219],"(71.4%)":[220],"Conclusions:":[223],"Final":[224],"suggests":[228],"OS":[232],"a":[240],"after":[248],"progression":[249],"on":[250],"inhibitors.":[252]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-22T00:00:00"}